- Thanks to a recent $345 million convertible debt offering, Depomed now holds over $560 million in cash on hand.
- Based on our analysis of previous transaction, we believe Depomed's model is working. We have identified a few potential targets for the company.
- Based on the current market capitalization and the potential to acquire new products that plug into the model, we believe Depomed's stock has tremendous near-term upside potential.
Please read the article on Seeking-Alpha: LINK